Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
Terri P McVeigh, Michael J Kerin Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway, Galway, Republic of Ireland Abstract: Implementation of the Oncotype DX assay has led to a change in the manner in which chemotherapy is utilized in pat...
Guardado en:
Autores principales: | McVeigh TP, Kerin MJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4019693c5b824749a62d1efb2f4690df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling
por: Ilana Schlam, et al.
Publicado: (2021) -
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
por: Richard Buus, et al.
Publicado: (2021) -
X-RAY DIAGNOSTICS OF PATHOLOGY OF MUSCULOSKELETAL SYSTEM USING DX-D FULL LEG FULL SPINE SYSTEM
por: N. A. Pozdeeva, et al.
Publicado: (2013) -
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor
por: García,Patricia, et al.
Publicado: (2020) -
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults
por: Una Mary McVeigh, et al.
Publicado: (2021)